Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortReduces urine production; treats bedwetting and diabetes insipidus.Calms an overactive bladder.
Body systemHormones & BonesKidney & Bladder
Drug classPituitary hormone analoguesBladder antimuscarinics
SupplyPrescription onlyPrescription only
Main usesBedwetting, Night-time urination (nocturia), Arginine vasopressin deficiency (diabetes insipidus), Mild haemophilia A and von Willebrand diseaseOveractive bladder, Bedwetting in children (second line), Excessive sweating (off-label)
How it worksTells your kidneys to make less urine.Relaxes the bladder so it holds more.
Starts working——
Half-life2–4 hours2–5 hours
Typical adult doseBedwetting: 200–400 micrograms tablet (120–240 micrograms melt) at bedtime.2.5–5 mg two or three times a day, or 5–20 mg modified-release once a day.
FormsTablet, Melt (under the tongue), Nasal spray, InjectionTablet, Modified-release tablet, Patch, Gel
Common side effectsHeadache, Stomach pain, NauseaDry mouth, Constipation, Blurred vision, Drowsiness
Serious side effectsLow sodium causing headache, vomiting, confusion or seizuresConfusion in older people, Urinary retention, Overheating (reduced sweating)
Don't take if——
Alcohol——
PregnancyGenerally considered safeUsed for diabetes insipidus in pregnancy.Use with cautionLimited data.
Breastfeeding——
In use since19781975
Brand namesUnited States: DDAVP, NocdurnaUnited Kingdom: DDAVP, DesmoMelt, NoqdirnaIndia: Minirin, D-VoidUnited States: Ditropan XL, OxytrolUnited Kingdom: Lyrinel XL, KenteraIndia: Oxyspas, Cystran
Legal status——
ATC codeH01BA02G04BD04

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker